Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Myeloproliferative Disorders × 30 days × Clear all

Status

Sponsor Class

OTHER 18 INDUSTRY 9 NIH 5 NETWORK 2 OTHER_GOV 1

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 7 Uterine Cervical Neoplasms 5 Stomach Neoplasms 3 Recurrence 3 Neoplasms 3 Sleep Initiation and Maintenance Disorders 2 Sarcopenia 2 Pancreatic Neoplasms 2 Lung Neoplasms 2 Gastrointestinal Neoplasms 2 Disease 2 Depression 2 Colorectal Neoplasms 2 Carcinoma, Renal Cell 2 Vulvar Neoplasms 1 Uterine Hemorrhage 1 Urinary Bladder Neoplasms 1 Spondylitis, Ankylosing 1 Skin Neoplasms 1 Sexual Dysfunction, Physiological 1 Sarcoglycanopathies 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pneumonia 1 Pilonidal Sinus 1 Patient Satisfaction 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Cyst 1 Pancreatic Cancer Metastatic to Liver 1 Pain, Postoperative 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05440838 2026-03-06

BioPredictor

University Hospital, Angers

Myeloproliferative Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡